MAPT and Alzheimer disease: In clinical practice, AD is typically first characterized by progressive clinical changes in memory and behavior, and subsequently through imaging changes that indirectly reflect AD neuropathology (i.e. misfolded proteins, tau and amyloid-Beta (Aβ)) (Braak and Braak, 1991, Braak et al., 2006, Hyman et al., 2012).